CIK 0002091349
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
First Tracks Biotherapeutics, Inc.
Sign in to watch- Ticker
- TRAX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 395003207
- Phone
- +1 212-373-3000
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- Biopharma Company, Inc.
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- EFFECT Other Notice of Effectiveness
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- S-1 Offering Registration Statement
- 8-K Event Material agreement
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- 8-K Event Regulation FD disclosure · Other events
- 4 Exercise or conversion Director acquired 1,300 shares (option exercise)
- 4 Open-market sale Director sold 39,265 shares at $44.78 ($1,758,145)
- 144 Insider Sale of Securities
- 4 Derivatives Options or other derivatives
Page 1 of 5 · 100 filings